Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AMY HARA HIRSH

Allopathic & Osteopathic Physicians Allergy & Immunology Allergy

NPI
1114959319
CMS profile
186515
Location
ATLANTA, GA

General Payments · PY2018–2024

$13,442.50

  • Reported across 301 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,254.19

56 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,254.19 56

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
CSL Behring $212.61 9
GENZYME CORPORATION $169.64 7
BioCryst US Sales Co., LLC $166.99 11
OptiNose US, Inc. $100.44 3
Acerta Pharma LLC $98.42 4
PFIZER INC. $95.48 4
Pharming Healthcare, Inc. $91.48 4
GlaxoSmithKline, LLC. $69.79 3
Grifols USA, LLC $61.43 3
Takeda Pharmaceuticals U.S.A., Inc. $54.33 2
Genentech USA, Inc. $49.09 2
Amgen Inc. $40.18 2
Incyte Corporation $23.40 1
Kaleo, Inc. $20.91 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $879.86 53
PY2019 $763.43 39
PY2020 $7,450.69 24
PY2021 $1,015.94 33
PY2022 $1,048.92 49
PY2023 $1,029.47 47
PY2024 $1,254.19 56

Payment records · PY2024 (56)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $20.09 01/18/2024 Food and Beverage Undisputed 01/23/2026 1111599558 CMS
Amgen Inc. $20.09 02/15/2024 Food and Beverage Undisputed 01/23/2026 1111599560 CMS
AstraZeneca Pharmaceuticals LP $20.98 03/28/2024 Food and Beverage Undisputed 01/23/2026 1105443922 CMS
AstraZeneca Pharmaceuticals LP $21.87 07/26/2024 Food and Beverage Undisputed 01/23/2026 1104603972 CMS
AstraZeneca Pharmaceuticals LP $27.19 08/26/2024 Food and Beverage Undisputed 01/23/2026 1104774946 CMS
AstraZeneca Pharmaceuticals LP $28.38 09/05/2024 Food and Beverage Undisputed 01/23/2026 1104438253 CMS
BioCryst US Sales Co., LLC $12.64 01/10/2024 Food and Beverage Undisputed 01/23/2026 1117473362 CMS
BioCryst US Sales Co., LLC $21.76 02/12/2024 Food and Beverage Undisputed 01/23/2026 1117473504 CMS
BioCryst US Sales Co., LLC $16.66 02/23/2024 Food and Beverage Undisputed 01/23/2026 1117472334 CMS
BioCryst US Sales Co., LLC $17.44 03/14/2024 Food and Beverage Undisputed 01/23/2026 1117475140 CMS
BioCryst US Sales Co., LLC $6.85 04/19/2024 Food and Beverage Undisputed 01/23/2026 1117476204 CMS
BioCryst US Sales Co., LLC $16.34 05/14/2024 Food and Beverage Undisputed 01/23/2026 1117479640 CMS
BioCryst US Sales Co., LLC $14.53 06/06/2024 Food and Beverage Undisputed 01/23/2026 1117469821 CMS
BioCryst US Sales Co., LLC $17.34 07/12/2024 Food and Beverage Undisputed 01/23/2026 1117470216 CMS
BioCryst US Sales Co., LLC $8.56 08/02/2024 Food and Beverage Undisputed 01/23/2026 1117472222 CMS
BioCryst US Sales Co., LLC $18.47 08/29/2024 Food and Beverage Undisputed 01/23/2026 1117480384 CMS
BioCryst US Sales Co., LLC $16.40 11/14/2024 Food and Beverage Undisputed 01/23/2026 1117477144 CMS
CSL Behring $22.31 01/25/2024 Food and Beverage Undisputed 01/23/2026 1134647937 CMS
CSL Behring $18.80 02/23/2024 Food and Beverage Undisputed 01/23/2026 1134647951 CMS
CSL Behring $19.65 03/22/2024 Food and Beverage Undisputed 01/23/2026 1134647963 CMS
CSL Behring $21.96 04/16/2024 Food and Beverage Undisputed 01/23/2026 1134647975 CMS
CSL Behring $18.42 05/23/2024 Food and Beverage Undisputed 01/23/2026 1134647993 CMS
CSL Behring $34.84 07/01/2024 Food and Beverage Undisputed 01/23/2026 1134648005 CMS
CSL Behring $28.39 08/22/2024 Food and Beverage Undisputed 01/23/2026 1134648027 CMS
CSL Behring $28.57 09/09/2024 Food and Beverage Undisputed 01/23/2026 1134648029 CMS
CSL Behring $19.67 11/19/2024 Food and Beverage Undisputed 01/23/2026 1134648075 CMS
Genentech USA, Inc. $28.81 11/07/2024 Food and Beverage Undisputed 01/23/2026 1132975557 CMS
Genentech USA, Inc. $20.28 12/05/2024 Food and Beverage Undisputed 01/23/2026 1132975555 CMS
GENZYME CORPORATION $20.91 02/01/2024 Food and Beverage Undisputed 01/23/2026 1139675291 CMS
GENZYME CORPORATION $31.14 04/08/2024 Food and Beverage Undisputed 01/23/2026 1139675315 CMS
GENZYME CORPORATION $5.10 04/18/2024 Food and Beverage Undisputed 01/23/2026 1139675323 CMS
GENZYME CORPORATION $35.99 05/30/2024 Food and Beverage Undisputed 01/23/2026 1139675331 CMS
GENZYME CORPORATION $33.22 06/24/2024 Food and Beverage Undisputed 01/23/2026 1139675349 CMS
GENZYME CORPORATION $20.77 07/15/2024 Food and Beverage Undisputed 01/23/2026 1139675373 CMS
GENZYME CORPORATION $22.51 10/31/2024 Food and Beverage Undisputed 01/23/2026 1139675443 CMS
GlaxoSmithKline, LLC. $29.60 02/08/2024 Food and Beverage Undisputed 01/23/2026 1116253495 CMS
GlaxoSmithKline, LLC. $21.99 09/12/2024 Food and Beverage Undisputed 01/23/2026 1116478373 CMS
GlaxoSmithKline, LLC. $18.20 11/18/2024 Food and Beverage Undisputed 01/23/2026 1115926124 CMS
Grifols USA, LLC $18.72 02/05/2024 Food and Beverage Undisputed 01/23/2026 1124751461 CMS
Grifols USA, LLC $21.64 04/05/2024 Food and Beverage Undisputed 01/23/2026 1124751463 CMS
Grifols USA, LLC $21.07 09/30/2024 Food and Beverage Undisputed 01/23/2026 1124751459 CMS
Incyte Corporation $23.40 10/23/2024 Food and Beverage Undisputed 01/23/2026 1141302455 CMS
kaleo, Inc. $20.91 05/09/2024 Food and Beverage Undisputed 01/23/2026 1126622613 CMS
Optinose US, Inc. $70.40 02/23/2024 Food and Beverage Undisputed 01/23/2026 1142185795 CMS
Optinose US, Inc. $15.14 04/11/2024 Food and Beverage Undisputed 01/23/2026 1142185833 CMS
Optinose US, Inc. $14.90 09/19/2024 Food and Beverage Undisputed 01/23/2026 1142185863 CMS
PFIZER INC. $25.56 02/29/2024 Food and Beverage Undisputed 01/23/2026 1131056774 CMS
PFIZER INC. $22.01 09/16/2024 Food and Beverage Undisputed 01/23/2026 1131967257 CMS
PFIZER INC. $26.23 11/21/2024 Food and Beverage Undisputed 01/23/2026 1131200144 CMS
PFIZER INC. $21.68 12/02/2024 Food and Beverage Undisputed 01/23/2026 1130991118 CMS
Pharming Healthcare, Inc. $22.53 01/08/2024 Food and Beverage Undisputed 01/23/2026 1132150357 CMS
Pharming Healthcare, Inc. $21.08 03/25/2024 Food and Beverage Undisputed 01/23/2026 1132150363 CMS
Pharming Healthcare, Inc. $22.02 10/17/2024 Food and Beverage Undisputed 01/23/2026 1132150370 CMS
Pharming Healthcare, Inc. $25.85 11/11/2024 Food and Beverage Undisputed 01/23/2026 1132150377 CMS
Takeda Pharmaceuticals U.S.A., Inc. $27.42 01/23/2024 Food and Beverage Undisputed 01/23/2026 1137576928 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.91 02/19/2024 Food and Beverage Undisputed 01/23/2026 1137576932 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.